31 results
424B3
ELVN
Enliven Therapeutics Inc
30 Apr 24
Prospectus supplement
4:16pm
is declared effective by the SEC;
through the writing or settlement of options or other hedging transactions, whether through an options exchange … for purposes of this prospectus.
In connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging
PRE 14A
ELVN
Enliven Therapeutics Inc
15 Apr 24
Preliminary proxy
4:05pm
or controller or persons performing similar functions or our directors on our website or in a current report on Form 8-K.
Hedging and Pledging Prohibitions
We … have implemented robust policies that bar employees from hedging and pledging our stock. Directors, officers, employees, consultants, contractors
S-4
EX-10.2
shf2gxsc3q057
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
425
xdp6dae8z6wx3 j29n
13 Oct 22
Business combination disclosure
4:50pm
8-K
EX-10.2
ns62 fhek
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
8-K
EX-2.1
v0ol4w 69o1
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
8-K
EX-10.3
1sjaty5 gw1rin9k493
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
424B5
29xzu gsi0u001x
14 Jul 21
Prospectus supplement for primary offering
4:16pm
424B5
9oifp
13 Jul 21
Prospectus supplement for primary offering
4:20pm